Beyond fat loss, Tesamorelin increases lean body mass by 1.42 kg across randomized clinical trials, improves lipid profiles (reducing triglycerides by 48 mg/dL and total cholesterol by 8 mg/dL at 52 weeks), and lowers hepatic fat fraction by 4.9% at 12 months in patients with NAFLD
Bariatric surgery alters gastrointestinal anatomy and physiology, which can affect medication tolerability and efficacy, though tirzepatide's subcutaneous administration bypasses concerns about altered GI absorption
Glucagon Receptor Agonism This is where retatrutide breaks new ground
Telehealth providers assess eligibility through an intake process that reviews your health history, current medications, and weight metrics
The FDA does not review over-the-counter (OTC) supplements for safety, effectiveness, or quality before they hit the market
your mitochondria are fighting a complex metabolic battle